PEA bridging study terminated early

The ICA regret to announce the early termination of the PEA bridging study, a randomised, placebo-controlled, double-blind clinical trial to determine the efficacy of riociguat on pre- and post-operative pulmonary haemodynamic parameters in patients with severe operable CTEPH. The reasons for this difficult decision were slow enrolment and the additional limitations on clinical research imposed […]

Read More ...